- OrbiMed Advisors purchased 1,000,000 shares of Aspen Neuroscience (ASPE).
- Total transaction value stands at approximately $15.0 million.
- Purchase executed directly, not under a pre-scheduled Rule 10b5-1 trading plan.
Bullish AI Sentiment (+6.5 / 10)
Signal #136514 · Form 4 Insider
$ASPE SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $ASPE filing catalyst
Why did $ASPE trigger an AI stock catalyst alert?
$ASPE triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a Form 4 Insider filing (AI Score: +6.5/10). Headline: Aspen Neuroscience Insider OrbiMed Buys $15.0M in Common Stock. Key points: - OrbiMed Advisors purchased 1,000,000 shares of Aspen Neuroscience (ASPE). - Total transaction value stands at approximately $15.0 million. - Purchase executed directly, not under a pre-scheduled Rule 10b5-1 trading plan.
How did $ASPE stock react after the SEC filing?
After the Form 4 Insider for $ASPE, observed market reaction: T0 price $12.76. Past moves do not guarantee future results.
Where can I get real-time $ASPE SEC filing alerts?
Stock Catalyst AI pushes real-time Form 4 Insider alerts for $ASPE via Telegram and the VIP Web Terminal from €10/month.